Previous 10 | Next 10 |
Palisade Bio (NASDAQ:PALI) trades 11.3% down premarket after it entered into definitive agreements with several institutional and accredited investors for the purchase and sale in a registered direct offering of 3.65M shares at purchase price of $0.55/share. The company also ag...
CARLSBAD, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (the “Company” or “Palisade Bio”), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it ha...
Clinical stage biotech Palisade Bio (NASDAQ:PALI) and co-development partner Newsoara Biopharma have got regulatory clearance in China to proceed with their phase 3 trial to evaluate LB1148 for accelerated return of bowel function in adults undergoing bowel/abdominal surgery. PALI stock ...
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S. Food and Drug Administration to commence Phase 3 study Newsoara to fully fund Phase 3 program in China Under the Co-Development Agreement, commencement of P...
CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today provided a business outlook and outlined its expected near-term pipeline a...
CARLSBAD, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that members of management will participate in the Virtual Invest...
CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that of Palisade Bio, will participate in the 2022 Virtual Growth...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re seeing a lot of activity from penny stocks today and have put together a list of the top ones for investors to watch. Source: Shutterstock Penny stocks can experience wild volatility in a short period o...
Buying Penny Stocks Today? Here’s What You Need to Know If you’re looking for penny stocks to buy, there are plenty of options to choose from. While early morning gainers like Kaixin Auto Holdings ( NASDAQ: KXIN ) and Bitnile Holdings Inc. ( NYSE: NILE ) are making...
Clinical-stage biotech, Palisade Bio (NASDAQ:PALI) is trading ~84% higher in the pre-market Tuesday after the company announced that the U.S. regulators cleared a Phase 3 trial for its lead candidate LB1148. With the “Study May Proceed” letter from the U.S. Food and Dr...
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...